Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with better patient outcomes compared to national findings, according to a recent study. Results of the 13-year Massachusetts experience were presented in a plenary session of the American Association for Thoracic Surgery’s 98th Annual Meeting.

The acquisition of biomedical equipment company Esaote SpA’s share capital was completed on April 19, the company recently announced, by a consortium of leading Chinese investors. The consortium is composed of major companies in the medical and healthcare technology sectors, as well as investment funds with significant experience in this field.

HeartSciences announced the results of a clinical study of its electrocardiography device that applies continuous wavelet transform signal processing and artificial intelligence. The study was serially conducted at The Icahn School of Medicine, Mount Sinai Hospital, New York, N.Y., and the West Virginia University (WVU) Heart and Vascular Institute, Morgantown, W. Va. The results were published online and in the April 17, 2018 issue of Journal of the American College of Cardiology (JACC).

The European Patent Office (EPO) has revoked Edward Lifesciences’ Corp.’s European patent EP 2,399,550 (‘550), ruling in favor of Boston Scientific and several other companies involved in an ongoing dispute related to transcatheter heart valves. The ‘550 patent is also the sole basis of Edwards’ infringement action against Boston Scientific in Ireland.

April 26, 2018 — Patients battling cardiovascular diseases, and even people hoping to prevent heart disease and stroke ...

The U.S. Food and Drug Administration (FDA) released a new Medical Device Safety Action Plan outlining how the agency will encourage innovation to improve safety, detect safety risks earlier, and keep doctors and patients better informed.